Currently, more than 70 memoranda and agreements have been concluded with various states. In 2025, significant documents were signed with Iran, Oman, Serbia and Vietnam. The main export positions of the Belarusian pharmaceutical industry are oncological, anti-inflammatory, rheumatoid drugs, as well as antibiotics. In 2024, more than 160.000 foreign patients from 159 countries received medical care in Belarusian institutions.